{"id":753634,"date":"2023-05-02T09:31:14","date_gmt":"2023-05-02T13:31:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/"},"modified":"2023-05-02T09:31:14","modified_gmt":"2023-05-02T13:31:14","slug":"quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/","title":{"rendered":"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ASHBURN, Va., May  02, 2023  (GLOBE NEWSWIRE) &#8212; Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \u201cCompany\u201d or \u201cQuoin\u201d), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company intends to release its first quarter 2023 financial results after the market closes on Monday, May 8, 2023. The Company will also host a conference call and webcast on May 9, 2023, at 8:30 am ET, to discuss the Company\u2019s first quarter 2023 financial results and to provide a corporate update.<\/p>\n<p align=\"justify\">The live call can be accessed by dialing 1-877-270-2148 (domestic) or 1-412-902-6510 (international).<\/p>\n<p align=\"justify\">The live and archived webcast of the call will be available on the Quoin Pharmaceuticals website under the Investors section: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CTtrcAv8xGOmCohMWinByRYzOZoCmqy8wjj0GoLKY5gaVetarxyzM8QgWmE6iiMx6Xpczffra8PmgEEdhmg7tCqA8nyx3xVQueVim3qL_QpdaZ1YkqglSN13bvq16fovxbEj2iEOH6IYOxtRX1MUAvqM323O129EnUrJMVJb2wNnmK9SNrK6svGSFxwKtaOlftfTIT82XZuxbdd3zpVO9LVfPx-lPIoHQ5mssHcH5hw=\" rel=\"nofollow noopener\" target=\"_blank\"><u>https:\/\/investors.quoinpharma.com\/news-and-events\/events-and-presentations<\/u><\/a><\/p>\n<p>\n        <strong>About Quoin Pharmaceuticals Ltd.<\/strong>\n      <\/p>\n<p align=\"justify\">Quoin Pharmaceuticals Ltd. is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin\u2019s innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis Bullosa and others. For more information, visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8iVVQDwdz1AtYtzksLWZlgFGP_H7ZugKQEntFFHoF2PJmjeSkYNekfth6MU41Kav7Pw9Nf8vHfm8Hebug0XU_rXuWsJd_mVr9PuVhM79iGg=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.quoinpharma.com<\/u><\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gL-KnzS3dqz8EOrKMRY9yuQnLMRmNs7gY48pBPHV2LAetDrZz6aFks4TA1POwYFsZT0LP9XckYfvw-r5_qYpA0XOasKBhsKmSYhn_1pEuF3sxSPRa7I5r712IKobCFg9\" rel=\"nofollow noopener\" target=\"_blank\"><u>LinkedIn<\/u><\/a> for updates.<\/p>\n<p align=\"justify\">\n        <strong>For further information, contact:<\/strong><br \/>\n        <br \/>Investor Relations<br \/>PCG Advisory<br \/>Stephanie Prince<br \/>sprince@pcgadvisory.com<br \/>(646) 863-6341<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NmMyNTEzMmYtNThlOS00ODY4LTliMTQtMDYzYjliOTI2YzI3LTEyMjEwMTA=\/tiny\/Quoin-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ASHBURN, Va., May 02, 2023 (GLOBE NEWSWIRE) &#8212; Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \u201cCompany\u201d or \u201cQuoin\u201d), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company intends to release its first quarter 2023 financial results after the market closes on Monday, May 8, 2023. The Company will also host a conference call and webcast on May 9, 2023, at 8:30 am ET, to discuss the Company\u2019s first quarter 2023 financial results and to provide a corporate update. The live call can be accessed by dialing 1-877-270-2148 (domestic) or 1-412-902-6510 (international). The live and archived webcast of the call will be available on the Quoin Pharmaceuticals website under the Investors section: https:\/\/investors.quoinpharma.com\/news-and-events\/events-and-presentations About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753634","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ASHBURN, Va., May 02, 2023 (GLOBE NEWSWIRE) &#8212; Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \u201cCompany\u201d or \u201cQuoin\u201d), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company intends to release its first quarter 2023 financial results after the market closes on Monday, May 8, 2023. The Company will also host a conference call and webcast on May 9, 2023, at 8:30 am ET, to discuss the Company\u2019s first quarter 2023 financial results and to provide a corporate update. The live call can be accessed by dialing 1-877-270-2148 (domestic) or 1-412-902-6510 (international). The live and archived webcast of the call will be available on the Quoin Pharmaceuticals website under the Investors section: https:\/\/investors.quoinpharma.com\/news-and-events\/events-and-presentations About &hellip; Continue reading &quot;Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T13:31:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET\",\"datePublished\":\"2023-05-02T13:31:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/\"},\"wordCount\":243,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/\",\"name\":\"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=\",\"datePublished\":\"2023-05-02T13:31:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/","og_locale":"en_US","og_type":"article","og_title":"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET - Market Newsdesk","og_description":"ASHBURN, Va., May 02, 2023 (GLOBE NEWSWIRE) &#8212; Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \u201cCompany\u201d or \u201cQuoin\u201d), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company intends to release its first quarter 2023 financial results after the market closes on Monday, May 8, 2023. The Company will also host a conference call and webcast on May 9, 2023, at 8:30 am ET, to discuss the Company\u2019s first quarter 2023 financial results and to provide a corporate update. The live call can be accessed by dialing 1-877-270-2148 (domestic) or 1-412-902-6510 (international). The live and archived webcast of the call will be available on the Quoin Pharmaceuticals website under the Investors section: https:\/\/investors.quoinpharma.com\/news-and-events\/events-and-presentations About &hellip; Continue reading \"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-02T13:31:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET","datePublished":"2023-05-02T13:31:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/"},"wordCount":243,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/","name":"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=","datePublished":"2023-05-02T13:31:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTk0NCM1NTY5NTQwIzIyMDk0NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quoin-pharmaceuticals-announces-first-quarter-2023-financial-results-and-corporate-update-conference-call-to-be-held-on-tuesday-may-9-2023-at-830-am-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753634"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753634\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}